These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1654494)

  • 21. [Infant mortality and its causes in a sub-district of the Ivory Coast].
    N'Guessan Diplo L; Rey JL; Soro B; Coulibaly A
    Med Trop (Mars); 1990; 50(4):429-32. PubMed ID: 1963915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Appropriate age for measles vaccination in the United States.
    Orenstein WA; Markowitz L; Preblud SR; Hinman AR; Tomasi A; Bart KJ
    Dev Biol Stand; 1986; 65():13-21. PubMed ID: 3549395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Anti-measles antibodies in the first 2 years of life].
    Echevarría JM; Sainz C; Montón JL; González F; Crespo E; Morales E; Cortés M; Taracena B; Nájera R
    An Esp Pediatr; 1984 Jun; 20(9):847-53. PubMed ID: 6486579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Analysis of the incidence of measles in Karl-Marx-Stadt County with special reference to infants].
    Hajduk F; Weiss O; Starke G; Bigl S; Kluge D; Gericke E
    Z Gesamte Hyg; 1980; 26(10):762-4. PubMed ID: 7467502
    [No Abstract]   [Full Text] [Related]  

  • 25. Disappearance of measles antibody in Thai infants after birth.
    Vanprapar N; Chavalittamrong B; Chearskul S; Pimolpan V
    Southeast Asian J Trop Med Public Health; 1983 Dec; 14(4):488-90. PubMed ID: 6673124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Measles vaccination: study of humoral immunity in children vaccinated in the Tunis region].
    Arrouji A; Mirchamsy H; Marnissi A
    Arch Inst Pasteur Tunis; 1982 Mar; 59(1):173-80. PubMed ID: 7181563
    [No Abstract]   [Full Text] [Related]  

  • 27. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
    Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC
    J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity of standard dose Edmonston-Zagreb measles vaccine in highland Papua New Guinean children from four months of age.
    Rogers S; Sanders RC; Alpers MP
    J Trop Med Hyg; 1991 Apr; 94(2):88-91. PubMed ID: 2023293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune status following measles vaccination in infants and evaluation for the need of revaccination.
    Dutta AK; Singhal PK; Khare S; Kumari S; Mathur R; Mullick DN
    Indian Pediatr; 1989 Aug; 26(8):765-72. PubMed ID: 2620977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of AIK-C measles vaccine in infants at 6 months with Schwarz vaccine at 9 months: a randomized controlled trial in Ghana.
    Nkrumah FK; Osei-Kwasi M; Dunyo SK; Koram KA; Afari EA
    Bull World Health Organ; 1998; 76(4):353-9. PubMed ID: 9803586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Measles & rubella hemagglutination inhibition antibodies in women of child-bearing age and the time of decline of maternally acquired antibodies among neonates and infants].
    Xü FG
    Zhonghua Liu Xing Bing Xue Za Zhi; 1985 Feb; 6(1):9-11. PubMed ID: 3995579
    [No Abstract]   [Full Text] [Related]  

  • 32. Trial of Edmonston-Zagreb measles vaccine in infants aged under nine months.
    Pongrithsukda V; Gluck R; Suwatanapongched S; Kaewmalung P; Muyakul J
    Southeast Asian J Trop Med Public Health; 1991 Sep; 22(3):347-50. PubMed ID: 1818384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimum age for measles immunization in Romania.
    Biberi-Moroeanu S; Tiţeica-Boldeanu M; Munţiu A; Petrenco M; Suter C
    Virologie; 1986; 37(1):3-8. PubMed ID: 3962178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Studies on the persistence of immunity 14-15 years after vaccination with a live measles vaccine].
    Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):389-91. PubMed ID: 2598095
    [No Abstract]   [Full Text] [Related]  

  • 35. [Immunity against measles in mother-child binomials].
    Calderón E; Martin Sosa S; Milovanovic MV; Alvarez A; De la L
    Bol Med Hosp Infant Mex; 1977; 34(1):1-12. PubMed ID: 836708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maternally derived measles immunity in children of naturally infected and vaccinated mothers.
    Jenks PJ; Caul EO; Roome AP
    Epidemiol Infect; 1988 Oct; 101(2):473-6. PubMed ID: 3053223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measles virus haemagglutination-inhibition antibodies among pregnant and non-pregnant women in the vaccine era in Harare, Zimbabwe.
    Obi CL; Tswana SA; Moyo SR; Berejena C
    Cent Afr J Med; 1996 May; 42(5):135-8. PubMed ID: 8771931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Post-vaccination anti-poliomyelitis seroprevalence in an urban setting in Abidjan].
    Akoua-Koffi G; Thonnon J; Kouassi-Renaud M; Dosso M; Ehouman A
    Bull Soc Pathol Exot; 1995; 88(3):117-20. PubMed ID: 8555765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measles vaccination in the presence of maternal antibodies primes for a balanced humoral and cellular response to revaccination.
    Bertley FM; Ibrahim SA; Libman M; Ward BJ
    Vaccine; 2004 Dec; 23(4):444-9. PubMed ID: 15530692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Passive transmission and persistence of naturally acquired or vaccine-induced maternal antibodies against measles in newborns.
    Leuridan E; Van Damme P
    Vaccine; 2007 Aug; 25(34):6296-304. PubMed ID: 17629601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.